All hospital visitors required to be vaccinated or have a negative COVID-19 test.

  • Inpatients in our Christiana, Wilmington and Union hospitals may have one visitor daily between 10 a.m. and 8 p.m. The visitor must be 16 or older.
  • Patients having outpatient surgery may have one support person accompany them. Support persons must be 16 or older.
  • All visitors and surgical support people must show proof of vaccination OR a negative COVID-19 test within the prior 72 hours.

Before visiting, click here for more details about visitation.

Visit or for local vaccination and testing sites.

All visitors are required to wear masks.

For COVID-19 safety, all visitors to ChristianaCare facilities and services are required to wear masks. This includes visitors who are vaccinated. Please read our visitor guidelines before arrival.

Monoclonal Antibody Treatment

ChristianaCare receives new monoclonal antibody treatment to help those at highest risk of complications from COVID-19

ChristianaCare has a treatment for COVID-19 called “monoclonal antibodies.” The product that we have is casirivimab/imdevimab (produced by Regeneron).

Monoclonal antibodies are not a cure. However, for patients at highest risk from COVID-19, they may help keep symptoms from becoming more serious. They may also help shorten the amount of time you are sick from COVID-19 and/or keep you from needing to be in the hospital.

The United States Food and Drug Administration (FDA) has authorized this therapy for Emergency Use. The United States Government has purchased a limited number of doses and is distributing them to state health departments. We have infused over 600 patients as of May 2021.

There are certain criteria high-risk patients who are COVID-19-positive and who meet very strict FDA criteria will qualify for this therapy.

To qualify, you must:

  • Have tested positive for COVID-19 with either a PCR or rapid test
  • Have symptoms that are mild to moderate and have started within the last 10 days.
  • Weigh at least 88 pounds and also meet at least one of the following criteria:
    • Age 65 and older
    • Obesity or being overweight (for example, adults with BMI >25 kg/m2, or if age 12-17, have BMI ≥85th percentile for their age and gender based on CDC growth charts
    • Pregnancy
    • Chronic kidney disease
    • Diabetes
    • Immunosuppressive disease or immunosuppressive treatment
    • Cardiovascular disease (including congenital heart disease) or hypertension
    • Chronic lung diseases (for example, chronic obstructive pulmonary disease, asthma [moderate-to-severe], interstitial lung disease, cystic fibrosis and pulmonary hypertension)
    • Sickle cell disease
    • Neurodevelopmental disorders (for example, cerebral palsy) or other conditions that confer medical complexity (for example, genetic or metabolic syndromes and severe congenital anomalies)
    • Having a medical-related technological dependence (for example, tracheostomy, gastrostomy, or positive pressure ventilation (not related to COVID-19))

This investigational treatment is not authorized for use in patients:

  • who are hospitalized due to COVID-19; or
  • who need oxygen therapy due to COVID-19; or
  • who need increased oxygen due to COVID-19 or who are on chronic oxygen therapy due to a non-COVID-19 health problem.

If you meet the criteria and your provider is within ChristianaCare, they can place a referral to activate the process. If your provider is not within ChristianaCare or you would like to make a referral as a patient, then please call 302-428-2121 and select provider option 1 for referrals.

More information about is available at and through these links:

Frequently Asked Questions

Monoclonal Antibodies are made in the lab to help your body fight COVID-19. They are not a cure, but they may help keep your symptoms from becoming more serious and they may help shorten the amount of time you are sick from COVID-19. This therapy is authorized for emergency use by the U.S. Food and Drug Administration (FDA) but it hasn’t been approved yet.

Not everyone needs or will receive this treatment. The goal is to help patients who are at highest risk for getting very sick and needing to be in the hospital for COVID-19 because of other health problems they already have. Eligible patients must have tested positive for COVID-19 within the last 5 days and meet strict criteria from the FDA. Please talk to your medical provider to see if you qualify.

There is a very limited supply of monoclonal antibody treatment available now through FDA. You can NOT get this therapy in the emergency department, in clinics or if you are already in the hospital with COVID-19. Please ask your medical provider if you meet the criteria.

The FDA has strict rules for who can receive monoclonal antibody treatment. The number of people who want the therapy will be greater than the amount of therapy available. . We are working hard with our medical providers to identify people at highest risk and make sure it goes first to those who need it most.

The treatment is given as an infusion (through the veins).

Monoclonal antibody therapy is still being studied, so it is possible that not all of the risks are known at this time. Talk with your health care provider to make this decision.

There is no cost to patients for monoclonal antibody therapy.

More information about is available at and through these links: